AEON Biopharma, Inc.
AEON
Rank in Stocks
#29030
AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in... AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key investigational products is ABP-450, a 900 kDa botulinum toxin complex, which is being advanced for therapeutic use in conditions such as migraine, cervical dystonia, and gastroparesis. The entity, originally known as ALPHAEON Corporation, adopted the name AEON Biopharma, Inc. in December 2019. Established in 2012, the company maintains its principal operations from Newport Beach, California.
Share Price
$0.1818
Last synced: 2026-11-09
Market Cap
$9.07M
Change (1 day)
3.35%
Change (1 year)
-80.06%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade AEON Biopharma, Inc. (AEON)
Category
Healthcare
Operating Margin for AEON Biopharma, Inc. (AEON)
Operating Margin as of November 2026 TTM: 0.00%
According to AEON Biopharma, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for AEON Biopharma, Inc. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | -100.00% |
| 2020 | -650.83% | -59.51% |
| 2019 | -1,607.57% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about AEON Biopharma, Inc.'s operating margin
What was AEON Biopharma, Inc.'s operating margin in 2025?
In 2025, AEON Biopharma, Inc.'s operating margin was 0.00%, compared with 0.00% in 2024.
How has AEON Biopharma, Inc.'s operating margin changed since 2020?
From 2020 to 2025, AEON Biopharma, Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2020 (-650.83%).
How does AEON Biopharma, Inc.'s operating margin compare with similar companies?
AEON Biopharma, Inc.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.